MARKET

BIIB

BIIB

Biogen
NASDAQ

Real-time Quotes | Nasdaq Last Sale

296.83
+2.98
+1.01%
Closed 18:47 12/13 EST
OPEN
298.00
PREV CLOSE
293.85
HIGH
304.00
LOW
294.89
VOLUME
1.95M
TURNOVER
--
52 WEEK HIGH
344.00
52 WEEK LOW
215.78
MARKET CAP
54.75B
P/E (TTM)
10.51
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BIIB and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 32 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

BIIB News

  • UPDATE 2-Sarepta shares surge after surprise approval of Duchenne Muscular Dystrophy drug
  • Reuters.2d ago
  • Merger Mating Dance: We Explore Who Gets The Rose Next - Sectors And Targets, Part I
  • Seeking Alpha - Article.2d ago
  • FDA approves Sarepta's muscular dystrophy drug
  • Yahoo Finance Video.2d ago
  • Biogen bails on gosuranemab after failed mid-stage study
  • seekingalpha.2d ago

More

Industry

Pharmaceuticals
-0.74%
Pharmaceuticals & Medical Research
-0.32%

Hot Stocks

Name
Price
%Change

About BIIB

Biogen Inc. is a biopharmaceutical company. The Company focuses on discovering, developing, manufacturing and delivering therapies to people living with serious neurological, rare and autoimmune diseases. The Company markets products, including TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA and FAMPYRA for multiple sclerosis (MS), FUMADERM for the treatment of severe plaque psoriasis and SPINRAZA for the treatment of spinal muscular atrophy (SMA). It also has a collaboration agreement with Genentech, Inc. (Genentech), a member of the Roche Group, with respect to RITUXAN for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia (CLL) and other conditions, GAZYVA indicated for the treatment of CLL and follicular lymphoma, and other anti-CD20 therapies. The Company's product candidate includes OCREVUS; Biosimilar adalimumab; Aducanumab; E2609; BIIB074; BAN2401; Opicinumab; CIRARA; BIIB061; BIIB054; BIIB067, and BIIB068.
More

Webull offers Biogen Inc (BIIB) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.